On October 13, 2022 we sat down to chat with Mel B. Feany about the molecular processes underlying the neuropathology of alpha-synuclein and Parkinson's disease. We focused on her findings implicating the actin cytoskeleton as an intermediary in mitochondrial dysfunction and other cellular mechanisms that contribute to pathology and cell death.
\nGuest:
\nMel B Feany, Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital and Harvard Medical School.
\nParticipating:
\nChris Gamblin, Department of Neuroscience, Developmental and Regenerative Biology, UTSA
\nHyoung-gon Lee, Department of Neuroscience, Developmental and Regenerative Biology, UTSA
\nHost:
\nCharles Wilson, Department of Neuroscience, Developmental and Regenerative Biology, UTSA